REFERENCE
Papa G, Fedele V, Rizzo MR, Fioravanti M, Leotta C, Solerte SB, Purrello F, Paolisso G.Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: a randomized, open-label, two-period, cross-over trial. Diabetes Care 29: 1918-1920, No. 8, Aug 2006
Rights and permissions
About this article
Cite this article
Fewer hypoglycaemic events with repaglinide than glibenclamide. React. Wkly. 1120, 3 (2006). https://doi.org/10.2165/00128415-200611200-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200611200-00008